[1] Gu D, Reynolds K, Wu X, et a1. Prevalence of the metabolic syndrome and overweight among adults in China[J]. Lancet, 2005, 365(9468): l398 [2] Xu H. Obesity and metabolic inflammation[J]. Drug Discov Today Dis Mech, 2013, 10(1/2): 21 [3] Morandi A, Maffeis C. Urogenital complications of obesity[J]. Best Pract Res Clin Endocrinol Metab, 2013, 27(2):209 [4] Chen H M, Li S J, Chen H P, et al. Obesity-related glomerulopathy in China: A case series of 90 pafients[J]. Am J Kidney Dis, 2008, 52(1): 58 [5] Li L S, Liu Z H. Epidemiologic data of renal diseases from a single unit in China:Analysis based on 13,519 renal biopsies[J]. Kidney Int, 2004, 66(3): 920 [6] Tang J H, Yan H D. Obesity-related glomerulopathy[J]. Inter J Urol Nephrol, 2009, 29(3): 394 [7] Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice[J]. J Clin Invest, 2008, 118(5): 1645 [8] Stumvoll M,Tschritter O, Fritsche A,et a1.Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity:Interaction with family history of type 2 diabetes [J]. Diabetes, 2002, 51(1): 37 [9] Maeda N,Shimomura I, Kishida K,et a1. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30[J]. Nat Med, 2002, 8(7): 731 [10] Yang X, Jansson P A, Nagaev I, et a1. Evidence of impaired adipogenesis in insulin resistance[J]. Biochem Biophys Res Commun, 2004, 3l7(4):1045 [11] Komatsu M, Ohfusa H, Sato Y, et a1. Strong inverse correlation between serum adiponectin level and heart rate-corrected QT interval inan apparently healthy population: A suggestion for a direct antiatherogenic effect of adiponectin[J]. Diabetes Care, 2004, 27(5): 1237 [12] Camici M, Galetta F, Abraham N, et al. Obesity-related glomerulopathy and podocyte injury: a mini review[J]. Front Biosci (Elite Ed), 2012, 4(1): 1058 [13] 韩燕华,苏园园,王晶晶,等.青春期多囊卵巢综合征血清瘦素水平与代谢状态的相关性研究[J].实用医学杂志,2009,25(12):1980 [14] 董华伟,申艳红,张雪娟.代谢综合征患者瘦素水平与肥胖及血压的关系[J].实用医学杂志,2010,26(1):78 [15] 邓西龙,张爱民,陈明,等.抗脂益肝汤联合二甲双胍对非酒精性脂肪肝患者胰岛素、瘦素抵抗的影响[J].实用医学杂志,2008,24(23):4040 [16] 张强,武明虎.肥胖致肾损伤的作用机制[J].医学综述,2007,13(21):1609 [17] 李颖,夏天,李荣.单纯性肥胖患者血清瘦素水平与尿微量白蛋白关系的 研究[J].天津医药,2012,40(5):446 [18] Burnett M S, Lee C W, Kinnaird T D, et al. The potential role of resistin in atherogenesis[J]. Atherosclerosis, 2005, 182(2): 241 [19] Calabro P, Samudio I , Willerson J T, et al. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways[J]. Circulation, 2004, 110 (21): 3335 [20] Nascimento M M, Pecoits-Filho R, Qureshi A R, et al. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study[J]. Nephrol Dial Transplant, 2004, 19( 11): 2803 [21] 董葆,谌贻璞.肥胖相关性肾病[J]. 临床内科杂志,2004,21(1):52 [22] Kambham N, Markowitz G S, Valeri A M, et a1. Obesity-related Glomerulopathy: an emerging epidemic[J]. Kidney Int, 2001, 59(4): 1498 [23] Darouich S, Goucha R, Jaafoura M H, et a1. Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis[J]. Ultrastruct Pathol, 2011, 35(4): 176 [24] 崔秀娴,国春玲,潘淑杰. 肥胖相关性肾病的临床表现及诊治进展[J]. 中外医疗,2011,30(17):69 [25] Cheng H, Dong H R, Lin R Q, et a1. Determination of normal value of glomerular size in Chinese adults by different measurement methods[J]. Nephrology (Carlton), 2012, 17(5): 488 [26] Chagnac A, Einstein T, Herman M, et a1. The effects of weight loss on renal function in patients with severe obesity[J]. J Am Soe Nephrol, 2003, 14(6): 1480 [27] Sebeková K, Lill M, Boor P, et a1. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system[J]. Am J Nephrol, 2009, 29(3): 164 [28] Adelman R. Obesity and renal disease[J]. Curt Opin Nephrol Heperten, 2002, 11(3): 33l [29] Tsuchida A, Yamauchi T, Takekawa S, et al. Peroxisome proliferator activated receptor (PPAR)α activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARα, PPARγ, and their combination[J]. Diabetes, 2005, 54(12): 3358 [30] 胡伟新. 肥胖相关性肾病的治疗[J]. 肾脏病与透析肾移植杂志,2005,14,(4):339
[1]张 茜,李洪发,刘俊玲,等. 快速扩弓后牙齿及牙槽骨变化的锥体束CT研究[J].天津医科大学学报,2014,20(01):57.
ZHANG Qian,LI Hong- fa,LIU Jun-ling,et al. Study on cone beam computed tomography study of tooth and alveolar bone changes after rapid maxillary expansion treatment [J].Journal of Tianjin Medical University,2014,20(02):57.
[2]马长辉,杨万松.血清丙氨酸转氨酶与ST段抬高型心肌梗死的相关性研究[J].天津医科大学学报,2014,20(02):116.
MA Chang-hui,YANG Wan-song.Clinical study of serum alanine aminotransferase in patients with acute ST-segment elevation myocardial infarction[J].Journal of Tianjin Medical University,2014,20(02):116.
[3]牛 健,于晓旭,李 雪,等.重组 CARDs TX 融合蛋白的表达纯化与复性[J].天津医科大学学报,2014,20(03):184.
NIU Jian,YU Xiao-xu,LI Xue,et al.Expression, purification and renaturation of recombinant CARDs TX fusion protein[J].Journal of Tianjin Medical University,2014,20(02):184.
[4]陈清刚,钱 明,王 毅,等.首发精神分裂症患者与超高危人群认知功能的对照研究[J].天津医科大学学报,2014,20(03):216.
CHEN Qing gang,QIAN Ming,WANG Yi,et al.Control study of cognitive function in ultra-high risk population of schizophrenia and first-episode schizophrenia patients[J].Journal of Tianjin Medical University,2014,20(02):216.
[5]单立新,高 越,王学菊.血清Cys C、RBP、尿mALb/ Cr检测在糖尿病肾病早期诊断中的价值[J].天津医科大学学报,2014,20(03):241.
[6]班新超,孙保存,谷彦军,等. CXCR4和CathepsinD在恶性纤维组织细胞瘤中的表达及意义[J].天津医科大学学报,2014,20(04):264.
BAN Xin-chao,SUN Bao-cun,GU Yan-jun,et al.Expression of CXCR4 and CathepsinD in malignant fibrous histiocytoma and their biological significance[J].Journal of Tianjin Medical University,2014,20(02):264.
[7]谭艳萍,吴校伟,刘 寅,等. 冠心病合并糖尿病患者药物涂层支架术后观察[J].天津医科大学学报,2014,20(05):414.
[8]叶剑飞 综述. microRNAs与肿瘤研究的新进展[J].天津医科大学学报,2014,20(05):416.
[9]李 姗,严海泓,章 萍,等. 长春新碱致双手麻木与麻痹性肠梗阻1例报道[J].天津医科大学学报,2014,20(05):373.
[10]台红祥,高卫真,吕梦翔,等. 动物骨骼透明标本制作方法的改进 [J].天津医科大学学报,2014,20(06):494.
作者简介 李颖(1980-),女,主治医师,硕士,研究方向:肥胖相关性肾病; 通信作者:夏天,E-mail: xiatian01@medmail.com.cn。